Literature DB >> 23011131

The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells.

Estelle Woldt1, Jérome Terrand, Mohamed Mlih, Rachel L Matz, Véronique Bruban, Fanny Coudane, Sophie Foppolo, Zeina El Asmar, Maria Eugenia Chollet, Ewa Ninio, Audrey Bednarczyk, Danièle Thiersé, Christine Schaeffer, Alain Van Dorsselaer, Christian Boudier, Walter Wahli, Pierre Chambon, Daniel Metzger, Joachim Herz, Philippe Boucher.   

Abstract

Vascular calcification is a hallmark of advanced atherosclerosis. Here we show that deletion of the nuclear receptor PPARγ in vascular smooth muscle cells of low density lipoprotein receptor (LDLr)-deficient mice fed an atherogenic diet high in cholesterol, accelerates vascular calcification with chondrogenic metaplasia within the lesions. Vascular calcification in the absence of PPARγ requires expression of the transmembrane receptor LDLr-related protein-1 in vascular smooth muscle cells. LDLr-related protein-1 promotes a previously unknown Wnt5a-dependent prochondrogenic pathway. We show that PPARγ protects against vascular calcification by inducing the expression of secreted frizzled-related protein-2, which functions as a Wnt5a antagonist. Targeting this signalling pathway may have clinical implications in the context of common complications of atherosclerosis, including coronary artery calcification and valvular sclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011131      PMCID: PMC3523725          DOI: 10.1038/ncomms2087

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  44 in total

1.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

Authors:  E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.

Authors:  Kerry L Tyson; Joanne L Reynolds; Rosamund McNair; Qiuping Zhang; Peter L Weissberg; Catherine M Shanahan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

3.  Wnt regulation of chondrocyte differentiation.

Authors:  Vicki Church; Tsutomu Nohno; Claudia Linker; Christophe Marcelle; Philippa Francis-West
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

4.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

5.  Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

Authors:  S A Steitz; M Y Speer; G Curinga; H Y Yang; P Haynes; R Aebersold; T Schinke; G Karsenty; C M Giachelli
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

6.  Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality.

Authors:  P W Wilson; L I Kauppila; C J O'Donnell; D P Kiel; M Hannan; J M Polak; L A Cupples
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

7.  Wnt proteins are lipid-modified and can act as stem cell growth factors.

Authors:  Karl Willert; Jeffrey D Brown; Esther Danenberg; Andrew W Duncan; Irving L Weissman; Tannishtha Reya; John R Yates; Roel Nusse
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

8.  Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation.

Authors:  Yingzi Yang; Lilia Topol; Heuijung Lee; Jinling Wu
Journal:  Development       Date:  2003-03       Impact factor: 6.868

9.  LRP: role in vascular wall integrity and protection from atherosclerosis.

Authors:  Philippe Boucher; Michael Gotthardt; Wei-Ping Li; Richard G W Anderson; Joachim Herz
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

10.  Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study.

Authors:  Craig R Walsh; L Adrienne Cupples; Daniel Levy; Douglas P Kiel; Marian Hannan; Peter W F Wilson; Christopher J O'Donnell
Journal:  Am Heart J       Date:  2002-10       Impact factor: 4.749

View more
  35 in total

1.  A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.

Authors:  Bindu Ramachandran; John N Stabley; Su-Li Cheng; Abraham S Behrmann; Austin Gay; Li Li; Megan Mead; Julia Kozlitina; Andrew Lemoff; Hamid Mirzaei; Zhijian Chen; Dwight A Towler
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

2.  Regulation of calcific vascular and valvular disease by nuclear receptors.

Authors:  Tamer Sallam; Yin Tintut; Linda L Demer
Journal:  Curr Opin Lipidol       Date:  2019-10       Impact factor: 4.776

3.  Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.

Authors:  Su-Li Cheng; Bindu Ramachandran; Abraham Behrmann; Jian-Su Shao; Megan Mead; Carolyn Smith; Karen Krchma; Yoanna Bello Arredondo; Attila Kovacs; Kapil Kapoor; Laurence M Brill; Ranjan Perera; Bart O Williams; Dwight A Towler
Journal:  Circ Res       Date:  2015-06-01       Impact factor: 17.367

Review 4.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

Review 5.  The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.

Authors:  Wai San Cheang; Xiao Yu Tian; Wing Tak Wong; Yu Huang
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

Review 6.  Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.

Authors:  Natalia Carrillo-López; Laura Martínez-Arias; Jorge B Cannata-Andía; Manuel Naves-Díaz; Sara Panizo; Sara Fernández-Villabrille; María Piedad Ruiz-Torres; Adriana Dusso
Journal:  Calcif Tissue Int       Date:  2021-02-13       Impact factor: 4.333

Review 7.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

8.  Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation.

Authors:  Zeina El Asmar; Jérome Terrand; Marion Jenty; Lionel Host; Mohamed Mlih; Aurélie Zerr; Hélène Justiniano; Rachel L Matz; Christian Boudier; Estelle Scholler; Jean-Marie Garnier; Diego Bertaccini; Danièle Thiersé; Christine Schaeffer; Alain Van Dorsselaer; Joachim Herz; Véronique Bruban; Philippe Boucher
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

Review 9.  Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders.

Authors:  Pooja M Bhatt; Ramiro Malgor
Journal:  Atherosclerosis       Date:  2014-09-03       Impact factor: 5.162

10.  Peroxisome Proliferator-Activated Receptor γ Level Contributes to Structural Integrity and Component Production of Elastic Fibers in the Aorta.

Authors:  Haw-Chih Tai; Pei-Jane Tsai; Ju-Yi Chen; Chao-Han Lai; Kuan-Chieh Wang; Shih-Hua Teng; Shih-Chieh Lin; Alice Y W Chang; Meei-Jyh Jiang; Yi-Heng Li; Hua-Lin Wu; Nobuyo Maeda; Yau-Sheng Tsai
Journal:  Hypertension       Date:  2016-04-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.